September 11, 2018 | Dory Benford
Johnny Lopez's research into the latest prostate cancer treatments, clinical trials, experimental therapies — anything to avoid chemotherapy, and a recommendation from a friend also battling prostate cancer, led him to Tanya Dorff, M.D., and City of Hope.
Fighting neuroblastomas by blocking their DNA replication, repair
April 17, 2014 | Hiu Chung So
Neuroblastoma is one of the deadliest childhood cancers, accounting for 15 percent of pediatric cancer deaths. For patients with high-risk neuroblastomas, the five-year survival rate is 40 to 50 percent even with the most rigorous treatments available today.
'Microenvironement' of lung cancer offers clues to survival
May 25, 2013 | Nicole White
In an effort to predict, treat and cure disease, scientists are exploring the smaller ecosystems that exist within the body. The tumor microenvironment – the site and surroundings where tumor cells grow – can hold important clues to help predict which cancer patients are at highest risk of their cancer spreading.
Physicians learn more by paying attention to failure
March 6, 2012 | City of Hope Staff
Regardless of their years of experience, doctors who learn from their failures as well as their successes become better at picking the right treatment for patients, according to a research team including City of Hope’s Meghana Bhatt , Ph.